Regulatory matters

11 posts

Formation of PharmEx Pakistan – Too Late, Too Little? – Asrar Qureshi’s Blog Post #1123

The Ministry of Commerce in Pakistan is launching PharmEx Pakistan to boost pharmaceutical exports, aiming to increase annual exports from $700 million to $3 billion. This public-private initiative, modeled after India’s Pharmexcil, seeks to enhance regulatory compliance and global visibility for Pakistani pharmaceuticals, while facing challenges in international competitiveness.
Share
View Post
  • 4 min

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

The blog post discusses the stagnation of pharmaceutical marketing due to reliance on outdated strategies, regulatory constraints, and risk aversion. It emphasizes the need for innovation through data-driven personalization, omnichannel engagement, and agile methodologies. A cultural shift toward collaboration and customer-centric approaches is essential for modernization and relevance in a changing landscape.
Share